Roth Capital Starts Sunesis Pharmaceuticals Inc. (SNSS) at Buy
Tweet Send to a FriendGet Alerts SNSS Hot Sheet
Price: $5.46 +0.92%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade SNSS Now!
Roth Capital initiates coverage on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) with a Buy. PT $6.00.
For more ratings news on Sunesis Pharmaceuticals Inc. click here and for the rating history of Sunesis Pharmaceuticals Inc. click here.
Shares of Sunesis Pharmaceuticals Inc. closed at $1.35 yesterday, with a 52 week range of $0.29-$3.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For more ratings news on Sunesis Pharmaceuticals Inc. click here and for the rating history of Sunesis Pharmaceuticals Inc. click here.
Shares of Sunesis Pharmaceuticals Inc. closed at $1.35 yesterday, with a 52 week range of $0.29-$3.16.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Topeka Capital Starts Laredo Petroleum (LPI) at Buy, Assets 'Undervalued'
- Barclays Starts T-Mobile US, (TMUS) at Equalweight
- Barclays Starts American Tower (AMT) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
